SpringWorks Therapeutics Inc
General ticker "SWTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.0B
SpringWorks Therapeutics Inc does not follow the US Stock Market performance with the rate: -15.0%.
Estimated limits based on current volatility of 2.9%: low 34.62$, high 36.67$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [21.40$, 46.98$]
- 2024-12-30 to 2025-12-30 estimated range: [19.34$, 42.79$]
Financial Metrics affecting the SWTX estimates:
- Negative: Non-GAAP EPS, $ of -5.14 <= 0.10
- Negative: Operating profit margin, % of -98.44 <= 1.03
- Negative: Operating cash flow per share per price, % of -10.14 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Inventory ratio change, % of 83.95 > 1.08
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term SWTX quotes
Long-term SWTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $5.45MM |
| Operating Expenses | $173.47MM | $280.67MM | $348.46MM |
| Operating Income | $-173.47MM | $-280.67MM | $-343.01MM |
| Non-Operating Income | $-0.44MM | $3.26MM | $17.91MM |
| R&D Expense | $101.68MM | $146.12MM | $150.49MM |
| Income(Loss) | $-173.91MM | $-277.42MM | $-325.10MM |
| Profit(Loss) | $-173.91MM | $-277.42MM | $-325.10MM |
| Stockholders Equity | $422.40MM | $558.19MM | $626.22MM |
| Inventory | $0.00MM | $0.00MM | $3.10MM |
| Assets | $452.49MM | $630.24MM | $725.79MM |
| Operating Cash Flow | $-127.88MM | $-161.56MM | $-222.79MM |
| Capital expenditure | $2.02MM | $10.20MM | $7.38MM |
| Investing Cash Flow | $83.59MM | $-215.60MM | $34.75MM |
| Financing Cash Flow | $1.16MM | $340.70MM | $296.64MM |
| Earnings Per Share* | $-3.57 | $-5.14 | $-5.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.